Thursday, August 25, 2016

TearLab Q3 revenue climbs 27%

TearLab Q3 revenue climbs 27%

November 5, 2015 by · Leave a Comment 

Tweet Third quarter revenue for TearLab (NASDAQ:TEAR; TSX:TLB) rose 27% to $6.6-million from $5.2-million a year ago. A net total of 228 TearLab systems were added in the third quarter. “We delivered a strong growth quarter both sequentially and compared with the prior year by expanding our device base and continuing to establish the clinical […]

TearLab Q2 revenue climbs 27%

TearLab Q2 revenue climbs 27%

August 7, 2015 by · Leave a Comment 

Tweet TearLab (NASDAQ:TEAR; TSX:TLB) has reported net revenue of $6.3-million for the second quarter this year, up 27%, from $5-million a year ago. A total of 394 orders for TearLab systems were booked in the second quarter, of which 303 were under the company’s new Flex program and 28 were purchased outside of the U.S. […]

TearLab names Wes Brazell as CFO

TearLab names Wes Brazell as CFO

July 6, 2015 by · Leave a Comment 

Tweet TearLab (NASDAQ:TEAR; TSX:TLB) has appointed Wes Brazell as CFO, with overall responsibility for operational finance, financial reporting, budgeting and strategic planning, as well as helping to manage the company’s relationships and interactions with the investment community. He  succeeds William Dumencu, who will continue to support the company in a consulting role until the end […]

TearLab posts 28% increase in Q1 revenue

TearLab posts 28% increase in Q1 revenue

May 7, 2015 by · Leave a Comment 

Tweet TearLab (NASDAQ:TEAR; TSX:TLB) reported first quarter net revenue of $5.4-million, up 28% from $4.2-million for the same period in 2014. A total of 261 orders for TearLab systems were booked in the first quarter. “We started 2015 with a fully staffed sales force, a better understanding of implementation, and, as evidenced by the continuing […]

TearLab in $35-million loan agreement with CRG

TearLab in $35-million loan agreement with CRG

March 5, 2015 by · Leave a Comment 

Tweet TearLab (NASDAQ:TEAR; TSX:TLB) has entered into a term loan agreement with CRG and certain of its affiliate funds, which provides TearLab with up to $35-million of available borrowing capacity. Under the accord, CRG is initially providing TearLab with $15-million. Up to $20-million of additional funding will be available to TearLab, at its option, through […]

TearLab Q3 revenue up 24%

TearLab Q3 revenue up 24%

November 5, 2014 by · Leave a Comment 

Tweet Third quarter net revenue for TearLab (NASDAQ:TEAR; TSX:TLB) totalled $5.2-million, up 24% from $4.2 million a year ago A net 118 TearLab Osmolarity systems were added to the company’s installed base in the third quarter. Of those, 50 systems were under the Masters Multi Unit Program, 21 were through its minimum use access programs, […]

TearLab to unveil second generation tear testing platform

TearLab to unveil second generation tear testing platform

August 14, 2014 by · Leave a Comment 

Tweet At its analyst and investor day on Sept. 23, TearLab (NASDAQ:TEAR; TSX:TLB) plans to cover its current business and growth strategies, international market opportunities recent R&D activities, including development of a second-generation point-of-care tear testing platform. On the second quarter conference call earlier this month, CEO Elias Vamvaskas said most of the research has been […]

TearLab Q2 revenue climbs 42%

TearLab Q2 revenue climbs 42%

August 7, 2014 by · Leave a Comment 

Tweet TearLab (NASDAQ:TEAR; TSX:TLB) has reported second quarter revenue of $5-million, up 42% from $3.5-million in the year earlier quarter and an increase of 19% sequentially from $4.2-million in the 2014 first quarter. A net 171 TearLab Osmolarity systems were added to the company’s installed base in the second quarter. Of those, 126 systems were […]

In conversation with Elias Vamvakas

In conversation with Elias Vamvakas

January 28, 2014 by · Leave a Comment 

Tweet As CEO of San Diego-based TearLab (NASDAQ:TEAR; TSX:TLB), eye care entrepreneur, Elias Vamvakas, has scored another home run with a medical device for the diagnosis and management of dry eye disease (DED). The TearLab Osmolarity System uses a novel lab-on-a-chip approach that requires less than 50 nanoliters of tear fluid in order to measure […]

Email Newsletters with Constant Contact
Google+